LD Micro Invitational
June 7-9, 2016
Luxe Hotel Sunset Boulevard (Los Angeles)
The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies.
Giggles N' Hugs (GIGL)
Giggles N' Hugs (OTC: GIGL) is the first and only restaurant that brings together high-end, organic food with active, cutting-edge play and entertainment for children. Every Giggles N' Hugs location offers an upscale, family-friendly atmosphere with a dedicated play area that children 10 and younger absolutely love. The company features high-quality menus made from fresh and local foods, nightly entertainment such as magic shows, concerts, puppet shows and face painting, and hugely popular party packages. For more information, visit the company's website at www.gigglesnhugs.com.
Ener-Core (OTC: ENCR) designs, manufactures and has commercially deployed unique systems that generate base load, clean power from polluting waste gases including methane. Ener-Core's patented Power Oxidizer is the only solution of its kind that turns one of the most potent pollution sources into a profitable, "always on" source of clean energy. Ener-Core's technology offers an alternative to the flaring (burning) of gaseous pollution while generating operating efficiencies and ensuring compliance with costly environmental regulations. For more information, visit the company's website at www.ener-core.com.
Coffee Holding (JVA)
Coffee Holding (NASDAQ: JVA) is an integrated wholesale coffee roaster and dealer with core products divided into three categories: Wholesale Green Coffee, Private Label Coffee and Branded Coffee. The company's private label and branded coffee products are sold throughout the United States, Canada and abroad to supermarkets, wholesalers, and individually owned and multi-unit retail customers. Established in 1972, Coffee Holding has remained profitable through varying cycles in the coffee industry and the economy. For more information, visit the company's website at www.coffeeholding.com.
Full House Resorts (FLL)
Full House Resorts (NASDAQ: FLL) owns, develops and operates gaming facilities throughout the country. Its properties include Bronco Billy's Casino and Hotel in Cripple Creek, Colorado; Rising Star Casino Resort in Rising Sun, Indiana; Silver Slipper Casino and Hotel in Bay St. Louis, Mississippi; and Stockman's Casino in Fallon, Nevada. The company also operates the Grand Lodge Casino at the Hyatt Regency Lake Tahoe Resort, Spa and Casino in Incline Village, Nevada, under a lease agreement with the Hyatt organization. For more information, visit the company's website at www.fullhouseresorts.com.
Mynd Analytics (CNSO)
Mynd Analytics (OTC: CNSO) provides reference data and analytic tools for clinicians and researchers in psychiatry. The company's Psychiatric EEG Evaluation Registry, or PEER Online, is a new registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on Mynd Analytics' original physician-developed database, there are now more than 38,000 outcomes for over 10,000 unique patients in the PEER registry. The objective of PEER Online is to avoid trial and error pharmacotherapy, which is the dominant approach for treatment resistant patients. For more information, visit the company's website at www.fullhouseresorts.com.
MRI Interventions (MRIC)
MRI Interventions (OTC: MRIC) is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI guidance. The company's products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Its ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases and its ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. For more information, visit the company's website at www.mriinterventions.com.
CombiMatrix (NASDAQ: CBMX) provides molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. The company specializes in prenatal diagnostics, miscarriage analysis /recurrent pregnancy loss, pediatric genetics and pre-implantation genetic screening, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. For more information, visit the company's website at www.combimatrix.com.
Microvision (NASDAQ: MVIS) works with companies around the world to bring its revolutionary PicoP® display technology to market. The MicroVision PicoP® display technology is an embedded solution designed for OEMs that want to give their customers new and enhanced ways to view and share information whether for business collaboration, personal entertainment, driver safety or in whatever way their imaginations take them. To facilitate bringing products to market across all of the industries and markets that can benefit from enhanced mobile displays, MicroVision licenses its patented technology to companies that develop and manufacture high tech components and end user products. For more information, visit the company's website at www.microvision.com.
Cellectar Biosciences (CLRB)
Cellectar Biosciences (NASDAQ: CLRB) is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. These novel small-molecules have demonstrated highly selective uptake and retention in a broad range of cancers. Cellectar's PDC pipeline includes product candidates for cancer therapy and cancer diagnostic imaging. The company is also developing PDCs for targeted delivery of chemotherapeutics and plans to expand its PDC chemotherapeutic pipeline through in-house and collaborative R&D efforts. For additional information, visit the company's website at www.cellectarbiosciences.com.
NanoViricides (NYSE: NNVC) is a pre-clinical biotech company that has utilized its patented platform technology to rapidly create anti-viral drug candidates. The company has conducted tests on more than 6,000 animals infected with various strains of influenza, HIV, dengue/dengue hemorrhagic fever, Ebola, rabies, adenovirus of the eye as well as herpes infections of the skin and the eye without evidence of resistance, side effects or toxicity. Treatments for various forms of acute herpes infections are now being advanced through the pre-clinical process toward human trials. For more information, visit the company's website at www.nanoviricides.com.
A-Mark Precious Metals (AMRK)
Founded in 1965, A-Mark Precious Metals (NASDAQ: AMRK) is a full-service precious metals trading company offering a wide array of services and products, including gold, silver, platinum and palladium for storage and delivery in the form of coins, bars, wafers and grain. A-Mark's services include financing, leasing, consignment, hedging and a variety of customized financial programs. It is also an official distributor for many government mints throughout the world. The company has trading centers in Santa Monica, California and Vienna, and has the largest precious metals dealer network in North America, serving customers on six continents. For more information, visit the company's website at www.amark.com.
COPsync (NASDAQ: COYN) is America's largest law enforcement real-time information sharing, communication and data interoperability network. COPsync provides officers the ability to instantly access local, state, and federal law enforcement databases, efficiently gather information at the point of incident, and immediately share critical data with all officers on the COPsync Network. For more information, visit the company's website at www.copsync.com.
Rock Creek Pharmaceuticals (RCPI)
Rock Creek Pharmaceuticals (OTC: RCPI) is an emerging drug development company focused on the discovery, development and commercialization of new drugs, formulations and compounds that provide therapies for chronic and acute inflammatory diseases. The company's compound is a small molecule, cholinergic agonist that exhibits anti-inflammatory pharmacological characteristics, distinct from other anti-inflammatory drugs. Rock Creek's lead compound has been investigated extensively in pre-clinical studies resulting in several peer reviewed and published scientific journal articles, covering models of multiple sclerosis, Alzheimer's disease, and autoimmune thyroiditis. For more information, visit the company's website at www.rockcreekpharmaceuticals.com.
Adamis Pharma (ADMP)
Adamis Pharma (ADMP) is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of allergy and respiratory disease. The company's current specialty pharmaceutical product candidates include; the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-2000 for the treatment of bronchospasms. The company's wholly owned subsidiary, U.S. Compounding, is a 503B drug outsourcing facility that provides prescription medications to patients, physician clinics, hospitals and surgery centers throughout most of the United States. For more information, visit the company's website at www.adamispharmaceuticals.com.
Synacor (NASDAQ: SYNC) is a technology development, multiplatform services and revenue partner for video, internet and communications providers, device manufacturers, and enterprises. The company delivers modern, multiscreen experiences and advertising to their consumers that require scale, actionable data and sophisticated implementation. The company's white-label products, platforms and services empower its global customers to deliver curated and personalized media to their millions of consumers worldwide. For more information, visit the company's website at www.synacor.com.
CrowdGather (OTC: CRWG) is an investor, acquirer, operator and owner of digital assets in the consumer and cannabis sectors. In 2016, CrowdGather intends to launch a crowdfunding portal at CrowdGather to assist cannabis and digital startups in procuring financing. The Company's online publishing network is anchored by DIY community builder, www.Yuku.com while its cannabis holdings include long standing online communities WeedTracker (www.weedtracker.com) and RapMusic (www.rapmusic.com). For more information, visit the company's website at www.crowdgather.com.
TearLab (NASDAQ: TEAR) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity® Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. For more information, visit the company's website at www.tearlab.com.